CN106771193B - A kind of immunochromatographytest test kit of herpes simplex virus type II IgM antibody - Google Patents
A kind of immunochromatographytest test kit of herpes simplex virus type II IgM antibody Download PDFInfo
- Publication number
- CN106771193B CN106771193B CN201710008363.3A CN201710008363A CN106771193B CN 106771193 B CN106771193 B CN 106771193B CN 201710008363 A CN201710008363 A CN 201710008363A CN 106771193 B CN106771193 B CN 106771193B
- Authority
- CN
- China
- Prior art keywords
- colloidal gold
- herpes simplex
- simplex virus
- virus type
- line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
本发明属于生物医药领域,具体涉及一种单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒。所述试剂盒由试剂条和塑料卡组装而成,试剂条包括底板,底板上粘贴有带有检测线和质控线的反应膜,反应膜靠近检测线的一端依次叠加粘贴有胶体金垫、样品垫,反应膜靠近质控线的一端叠加粘贴有吸收垫,检测线包被了单纯疱疹病毒II型抗原,质控线包被了羊抗鼠IgG抗体,胶体金垫上包被了胶体金标记的鼠抗人IgM单克隆抗体。本发明试剂盒可显著降低环境因素(如低温、高湿)对检测过程和结果的影响,保障检测结果的灵敏度、准确度和稳定性。The invention belongs to the field of biomedicine, and in particular relates to an immunochromatographic detection kit for herpes simplex virus type II IgM antibody. The kit is assembled from a reagent strip and a plastic card. The reagent strip includes a bottom plate on which a reaction film with a detection line and a quality control line is pasted. The end of the reaction film close to the detection line is sequentially superimposed and pasted with a colloidal gold pad, The sample pad, the end of the reaction membrane near the quality control line is superimposed with an absorbent pad, the detection line is coated with herpes simplex virus type II antigen, the quality control line is coated with goat anti-mouse IgG antibody, and the colloidal gold pad is coated with colloidal gold markers mouse anti-human IgM monoclonal antibody. The kit of the invention can significantly reduce the influence of environmental factors (such as low temperature and high humidity) on the detection process and results, and ensure the sensitivity, accuracy and stability of the detection results.
Description
技术领域technical field
本发明属于生物医药领域,具体涉及一种单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒。The invention belongs to the field of biomedicine, and in particular relates to an immunochromatographic detection kit for herpes simplex virus type II IgM antibody.
背景技术Background technique
单纯疱疹病毒(Herpes Simplex Virus,HSV)属于人类疱疹病毒α亚科,是DNA双链病毒,人类是其唯一自然宿主。根据其抗原性质的不同,可分为单纯疱疹病毒I型(HSV-1型)型和单纯疱疹病毒II型(HSV-2型),两者之间的基因同源序列约为50%。HSV-1型多感染口、面、眼等腰部以上部位,而HSV-2型则通常感染生殖器及肛周等腰以下部位。疱疹的典型临床表现出皮肤粘膜上出现集簇性水疱、脓疱。溃疡和结痂。Herpes Simplex Virus (HSV) belongs to the human herpesvirus α subfamily, is a DNA double-stranded virus, and humans are its only natural host. According to the different antigenic properties, it can be divided into herpes simplex virus type I (HSV-1) type and herpes simplex virus type II (HSV-2 type), and the gene homologous sequence between the two is about 50%. The HSV-1 type usually infects the parts above the waist such as the mouth, face, and eyes, while the HSV-2 type usually infects the parts below the genitals and the perianal area. The typical clinical manifestations of herpes are clustered blisters and pustules on the skin and mucous membranes. Sores and scabs.
HSV-2型是引起生殖器疱疹最常见的原因,生殖器疱疹已经成为感染率最高的性传播感染之一。孕妇感染单纯疱疹病毒易引起胎儿畸形或分娩后婴儿出现疱疹病毒性脑炎等而严重致残疾病。近年来生殖器疱疹尤其是复发性生殖器的患病率无论在发达国家或是发展中国家均明显增加。80%以上的HSV-2型感染者并不表现出生殖器疱疹症状,或没有显著症状,不易被发现,但仍能间歇性的排毒,在不易察觉的情况下传染给别人。单纯疱疹病毒的特异性抗体和非特异性抗体均在感染后的最初几周内出现,因此,HSV-2型特异性IgM抗体的检测对于隐形感染和流行病学调查具有重要作用。HSV-2 is the most common cause of genital herpes, which has become one of the most prevalent sexually transmitted infections. Pregnant women infected with herpes simplex virus can easily cause fetal malformation or herpes virus encephalitis in babies after delivery, which can cause serious disability. In recent years, the prevalence of genital herpes, especially recurrent genital herpes, has increased significantly in both developed and developing countries. More than 80% of HSV-2 infected persons do not show symptoms of genital herpes, or have no significant symptoms, and are not easy to be found, but they can still intermittently detoxify and infect others without being easy to detect. Both HSV-specific and non-specific antibodies appear within the first few weeks after infection. Therefore, detection of HSV-2-specific IgM antibodies plays an important role in silent infection and epidemiological investigations.
目前,单纯疱疹病毒的实验室诊断方法有细胞培养、抗原检测、PCR、血清抗体检测等。细胞培养及PCR方法对实验场地等实验条件及人员的要求较高,均不能在大部分的实验室开展。检测抗原的直接免疫荧光或ELISA方法均需依赖相应的仪器设备,而且试剂多为进口,价格昂贵。血清抗体检测如常用的胶体金免疫层析法,其特异性强、灵敏度高、操作简捷等优点而并广泛应用,但是胶体金免疫层析法受环境和人为因素的影响较大,如当环境温度较低时(如冬季),层析速度慢,需延长反应时间,否则容易造成漏检;或放置于空气中过长时间,导致受潮,或当环境湿度过高,膜上毛细作用加强,点膜容易引起T线、C线变宽甚至扩散,影响检测过程和结果。因此,需对胶体金免疫层析法检测HSV-2型特异性IgM抗体的试剂盒进行优化,以得到一种受环境因素影响小、检测稳定性高的单纯疱疹病毒II型免疫层析检测试剂盒。Currently, laboratory diagnostic methods for HSV include cell culture, antigen detection, PCR, and serum antibody detection. Cell culture and PCR methods have high requirements on experimental conditions such as experimental sites and personnel, and cannot be carried out in most laboratories. The direct immunofluorescence or ELISA methods for detecting antigens need to rely on corresponding instruments and equipment, and most of the reagents are imported and expensive. Serum antibody detection, such as the commonly used colloidal gold immunochromatography, is widely used due to its strong specificity, high sensitivity, and simple operation. However, the colloidal gold immunochromatography is greatly affected by environmental and human factors, such as When the temperature is low (such as winter), the chromatography speed is slow, and the reaction time needs to be extended, otherwise it is easy to cause missed detection; or it is placed in the air for a long time, resulting in moisture, or when the ambient humidity is too high, the capillary action on the membrane is strengthened, Dot film is easy to cause T line, C line to widen or even spread, affecting the detection process and results. Therefore, it is necessary to optimize the kit for detecting HSV-2 type-specific IgM antibody by colloidal gold immunochromatography to obtain a herpes simplex virus type II immunochromatographic detection reagent that is less affected by environmental factors and has high detection stability. box.
发明内容Contents of the invention
为了解决现有技术中存在的问题(如胶体金免疫层析法受环境因素影响大,导致灵敏度和稳定性下降等),本发明提供了一种单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒,该试剂盒可显著降低环境因素对检测过程和结果的影响,保障检测结果的灵敏度、准确度和稳定性。In order to solve the problems existing in the prior art (such as colloidal gold immunochromatography is greatly affected by environmental factors, resulting in decreased sensitivity and stability, etc.), the invention provides an immunochromatographic detection of herpes simplex virus type II IgM antibody The kit, which can significantly reduce the impact of environmental factors on the detection process and results, and ensure the sensitivity, accuracy and stability of the detection results.
本发明提供的一种单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒,所述试剂盒由试剂条和塑料卡组装而成,所述试剂条包括底板,所述底板上粘贴有带有检测线(T)和质控线(C)的反应膜,所述反应膜靠近检测线(T)的一端依次叠加粘贴有胶体金垫、样品垫,所述反应膜靠近质控线(C)的一端叠加粘贴有吸收垫,所述反应膜上检测线(T)包被了单纯疱疹病毒II型抗原,所述反应膜上质控线(C)包被了羊抗鼠IgG抗体,所述胶体金垫上包被了胶体金标记的鼠抗人IgM单克隆抗体。The invention provides an immunochromatographic detection kit for herpes simplex virus type II IgM antibody, the kit is assembled from a reagent strip and a plastic card, the reagent strip includes a bottom plate, and the bottom plate is pasted with a The reaction membrane of the detection line (T) and the quality control line (C), the end of the reaction membrane close to the detection line (T) is superimposed and pasted with a colloidal gold pad and a sample pad in turn, and the reaction membrane is close to the quality control line (C) One end of the reaction membrane is superimposed and pasted with an absorbent pad, the detection line (T) on the reaction membrane is coated with herpes simplex virus type II antigen, the quality control line (C) on the reaction membrane is coated with goat anti-mouse IgG antibody, the The colloidal gold pad is coated with colloidal gold-labeled mouse anti-human IgM monoclonal antibody.
在本发明试剂盒中,所述反应膜由以下方法制得:用缓冲液将单纯疱疹病毒II型抗原稀释至包被浓度为0.8~1.2mg/ml,将羊抗鼠IgG抗体稀释至包被浓度为1.5~1.8mg/ml,在反应膜上分别划线单纯疱疹病毒II型抗原检测线和羊抗鼠IgG抗体质控线,划线后将反应膜置于干燥间,温度20~25℃,湿度小于30%,干燥4~5小时;In the kit of the present invention, the reaction membrane is prepared by the following method: dilute the herpes simplex virus type II antigen with a buffer to a coating concentration of 0.8-1.2 mg/ml, and dilute the goat anti-mouse IgG antibody to a coating concentration of 0.8-1.2 mg/ml. The concentration is 1.5-1.8mg/ml, and the detection line of herpes simplex virus type II antigen and the quality control line of goat anti-mouse IgG antibody are respectively drawn on the reaction membrane. After marking, the reaction membrane is placed in a drying room at a temperature of 20-25°C , the humidity is less than 30%, dry for 4 to 5 hours;
所述胶体金垫由以下方法制得:以氯金酸-柠檬酸三钠还原法制备直径为20nm的胶体金溶液,制备完成后取100ml胶体金液放在烧杯内,用0.2M K2CO3调至pH8.0,按100ml胶体金溶液加入2.0mg鼠抗人IgM单克隆抗体,再缓慢添加0.2M K2CO3将胶体金溶液调至pH9.5,添加K2CO3的时间为5分钟,然后室温搅拌30分钟,加入终浓度为10mg/ml牛血清白蛋白,1mg/ml聚乙烯吡咯烷酮封闭20~30分钟,12000r/m离心30分钟,弃上清,用缓冲液复溶至50ml,按1ml溶液铺20cm2的比例均匀地铺在玻璃纤维膜上,再置于干燥间,温度20~25℃,湿度小于30%,干燥4~5小时。The colloidal gold pad is prepared by the following method: a colloidal gold solution with a diameter of 20nm is prepared by the chloroauric acid-trisodium citrate reduction method, and after the preparation is completed, 100ml of the colloidal gold solution is placed in a beaker and mixed with 0.2MK 2 CO 3 Adjust to pH 8.0, add 2.0mg mouse anti-human IgM monoclonal antibody to 100ml colloidal gold solution, then slowly add 0.2M K 2 CO 3 to adjust the colloidal gold solution to pH 9.5, add K 2 CO 3 for 5 minutes , then stirred at room temperature for 30 minutes, added bovine serum albumin with a final concentration of 10mg/ml, 1mg/ml polyvinylpyrrolidone for blocking for 20-30 minutes, centrifuged at 12000r/m for 30 minutes, discarded the supernatant, and reconstituted to 50ml with buffer, Spread 1ml of the solution evenly on the glass fiber membrane at a ratio of 20cm 2 , and then place it in a drying room at a temperature of 20-25°C and a humidity of less than 30%, and dry for 4-5 hours.
进一步的,所述缓冲液由以下方法制得:称取0.06g的NaH2PO4·2H2O和0.58g的Na2HPO4·12H2O,加纯化水80.0mL,搅拌使充分溶解后加入0.80~0.90g的NaCl和0.5~2.0g烷基糖苷,充分混匀,定容至100ml,测定pH值为7.5~8.0。Further, the buffer solution is prepared by the following method: Weigh 0.06g of NaH 2 PO 4 ·2H 2 O and 0.58g of Na 2 HPO 4 ·12H 2 O, add 80.0 mL of purified water, stir to fully dissolve Add 0.80-0.90 g of NaCl and 0.5-2.0 g of alkyl glucoside, mix thoroughly, and set the volume to 100 ml, and measure the pH value to be 7.5-8.0.
再进一步的,所述烷基糖苷的碳链长度为C8~C10。Still further, the carbon chain length of the alkyl glycoside is C8-C10.
进一步的,所述反应膜为硝酸纤维素膜。Further, the reaction membrane is a nitrocellulose membrane.
进一步的,所述样品垫为玻璃纤维膜。Further, the sample pad is a glass fiber membrane.
在本发明的技术方案中,烷基糖苷是一种非离子表面活性剂,其兼具非离子和阴离子表面活性剂的特性,而发明人意外地发现在磷酸盐缓冲液中添加烷基糖苷,并且同时应用于反应膜和胶体金垫的制备中,可有效提高试剂盒在低温环境下的层析速度,并且减弱环境湿度对检测过程及结果的影响,从而提高检测结果的准确度和稳定性。这可能是因为烷基糖苷的非离子和阴离子特性,一方面在检测时能加快胶体金标记颗粒与配体结合形成复合物的速度,以及T线和C线的捕获速度,从而提高层析速度,所以即使在低温环境下检测反应时间也在20分钟以内;另一方面能提高胶体金标记颗粒和复合物稳定性,维持T线和C线的稳定,使其受环境湿度的影响大大减弱,一是能延长其使用期效,二避免因受潮导致检测过程受影响和检测结果不准确,从而保障检测结果的灵敏度、准确度和稳定性。In the technical scheme of the present invention, alkyl glycoside is a kind of nonionic surfactant, which has the characteristics of both nonionic and anionic surfactants, and the inventor unexpectedly found that adding alkyl glycoside in phosphate buffer, And it is applied to the preparation of reaction membrane and colloidal gold pad at the same time, which can effectively improve the chromatography speed of the kit in low temperature environment, and weaken the influence of ambient humidity on the detection process and results, thereby improving the accuracy and stability of the detection results . This may be due to the non-ionic and anionic properties of alkyl glycosides. On the one hand, it can accelerate the speed of colloidal gold-labeled particles and ligands to form complexes during detection, as well as the capture speed of T-line and C-line, thereby increasing the chromatography speed. , so even in a low temperature environment, the detection reaction time is within 20 minutes; on the other hand, it can improve the stability of colloidal gold-labeled particles and complexes, maintain the stability of T-line and C-line, and greatly weaken the influence of environmental humidity. First, it can prolong its service life, and second, it can avoid the influence of the detection process and inaccurate detection results due to moisture, so as to ensure the sensitivity, accuracy and stability of the detection results.
本发明试剂盒的检测方法为:1)将检测试剂及样本平衡至室温,取出试纸盒,平放;2)10μI血清、血浆样本,样本为全血时吸取20ul样本,加入到样本孔中,再立即在下部的缓冲液孔中加入100μL样本稀释液(生理盐水或PBS),5~20分钟内可判定结果。3)检测结果分析:阳性:出现紫红色质控线(C线)和检测线(T线)两条条带;阴性:只出现一条紫红色质控线(C线)条带;无效:未出现紫红色质控线(C线)条带,表明不正确的操作过程或试剂已变质损坏,实验无效,60分钟后检验结果也无效。The detection method of the kit of the present invention is: 1) balance the detection reagent and the sample to room temperature, take out the test paper box, and lay it flat; 2) 10 μl of serum and plasma samples, when the sample is whole blood, draw 20ul of the sample and add it to the sample hole , and immediately add 100 μL of sample diluent (normal saline or PBS) to the lower buffer well, and the result can be judged within 5 to 20 minutes. 3) Analysis of test results: Positive: Two bands of purple-red quality control line (C line) and test line (T-line) appear; Negative: only one band of purple-red quality control line (C line) appears; Invalid: no The appearance of purple-red quality control line (C line) strips indicates that the operation process is incorrect or the reagent has been deteriorated and damaged. The experiment is invalid, and the test result after 60 minutes is also invalid.
因此,与现有技术相比,本发明的优势在于:Therefore, compared with prior art, the advantage of the present invention is:
本发明单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒通过对缓冲液的优化,增加了烷基糖苷这一组分,同时对单纯疱疹病毒II型抗原、羊抗鼠IgG抗体的包被浓度,鼠抗人IgM单克隆抗体的标记浓度,以及胶体金标记时的pH值进行调整优化以显著降低环境因素对检测过程的影响,加快低温环境下的层析速度,提高试剂盒的耐潮性,从而保障检测结果的灵敏度、准确度和稳定性,并且延长试剂盒的使用期效。The immunochromatographic detection kit of herpes simplex virus type II IgM antibody of the present invention adds the component of alkyl glycoside by optimizing the buffer solution, and simultaneously coats herpes simplex virus type II antigen and goat anti-mouse IgG antibody Concentration, labeling concentration of mouse anti-human IgM monoclonal antibody, and pH value during colloidal gold labeling are adjusted and optimized to significantly reduce the impact of environmental factors on the detection process, speed up chromatography in low temperature environments, and improve the moisture resistance of the kit , so as to ensure the sensitivity, accuracy and stability of the test results, and prolong the service life of the kit.
具体实施方式Detailed ways
下面将进一步的详细说明本发明。需要指出的是,以下说明仅仅是对本发明要求保护的技术方案的举例说明,并非对这些技术方案的任何限制。本发明的保护范围以所附权利要求书记载的内容为准。The present invention will be further described in detail below. It should be pointed out that the following description is only an illustration of the technical solutions claimed in the present invention, and is not any limitation to these technical solutions. The protection scope of the present invention shall be determined by the contents described in the appended claims.
在本发明实施例和对比例中,单纯疱疹病毒II型抗原经单纯疱疹病毒II型G株培养、纯化获得,其他原料均源于市售,如羊抗鼠IgG抗体购自杭州启泰生物技术有限公司,鼠抗人IgM单克隆抗体购自上海鼎杰生物科技有限公司,C8~C10烷基糖苷(活性物52.0wt%)购自广州市西陆化工有限公司。In the examples and comparative examples of the present invention, the herpes simplex virus type II antigen was obtained by culturing and purifying the herpes simplex virus type II G strain, and other raw materials were obtained from the market, such as goat anti-mouse IgG antibody purchased from Hangzhou Qitai Biotechnology Co., Ltd. Co., Ltd., mouse anti-human IgM monoclonal antibody was purchased from Shanghai Dingjie Biotechnology Co., Ltd., and C8-C10 alkyl glycosides (active substance 52.0 wt%) were purchased from Guangzhou Xilu Chemical Co., Ltd.
实施例1、本发明单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒Embodiment 1, the immunochromatographic detection kit of herpes simplex virus type II IgM antibody of the present invention
本实施例的试剂盒由试剂条和塑料卡组装而成,所述试剂条的宽度为4mm,包括底板,所述底板上粘贴有带有检测线(T)和质控线(C)的反应膜,所述反应膜靠近检测线(T)的一端依次叠加粘贴有胶体金垫、样品垫,T线一端搭接胶体金垫的1/5处粘贴,样品垫搭接胶体金垫的1/3处粘贴;所述反应膜靠近质控线(C)的一端叠加粘贴有吸收垫,搭接吸样垫的1/10处粘贴,所述反应膜上检测线(T)包被了单纯疱疹病毒II型抗原,所述反应膜上质控线(C)包被了羊抗鼠IgG抗体,所述胶体金垫上包被了胶体金标记的鼠抗人IgM单克隆抗体。The test kit of the present embodiment is assembled by a reagent strip and a plastic card. The width of the reagent strip is 4 mm, and includes a base plate on which a test line (T) and a quality control line (C) are pasted on the base plate. A colloidal gold pad and a sample pad are superimposed and pasted on one end of the reaction film close to the detection line (T) in sequence, one end of the T line overlaps 1/5 of the colloidal gold pad, and the sample pad overlaps 1/5 of the colloidal gold pad. Paste at 3 places; the end of the reaction film close to the quality control line (C) is superimposed and pasted with an absorbent pad, and the 1/10 place of the overlapping suction pad is pasted, and the detection line (T) on the reaction film is coated with herpes simplex Virus type II antigen, the quality control line (C) on the reaction membrane is coated with goat anti-mouse IgG antibody, and the mouse anti-human IgM monoclonal antibody labeled with colloidal gold is coated on the colloidal gold pad.
所述反应膜由以下方法制得:用缓冲液将单纯疱疹病毒II型抗原稀释至包被浓度为0.8mg/ml,将羊抗鼠IgG抗体稀释至包被浓度为1.5mg/ml,在反应膜上分别划线单纯疱疹病毒II型抗原检测线和羊抗鼠IgG抗体质控线,划线后将反应膜置于干燥间,温度20℃,湿度小于30%,干燥5小时;The reaction membrane is prepared by the following method: the herpes simplex virus type II antigen is diluted to a coating concentration of 0.8 mg/ml with a buffer, and the goat anti-mouse IgG antibody is diluted to a coating concentration of 1.5 mg/ml. Scribe the detection line of herpes simplex virus type II antigen and the quality control line of goat anti-mouse IgG antibody on the membrane respectively. After scribing, place the reaction membrane in a drying room at a temperature of 20°C and a humidity of less than 30% for 5 hours;
所述胶体金垫由以下方法制得:以氯金酸-柠檬酸三钠还原法制备直径为20nm的胶体金溶液,制备完成后取100ml胶体金液放在烧杯内,用0.2M K2CO3调至pH8.0,按100ml胶体金溶液加入2.0mg鼠抗人IgM单克隆抗体,再缓慢添加0.2M K2CO3将胶体金溶液调至pH9.5,添加K2CO3的时间为5分钟,然后室温搅拌30分钟,加入终浓度为10mg/ml牛血清白蛋白,1mg/ml聚乙烯吡咯烷酮封闭20分钟,12000r/m离心30分钟,弃上清,用缓冲液复溶至50ml,按1ml溶液铺20cm2的比例均匀地铺在玻璃纤维膜上,再置于干燥间,温度20℃,湿度小于30%,干燥5小时。The colloidal gold pad is prepared by the following method: a colloidal gold solution with a diameter of 20nm is prepared by the chloroauric acid-trisodium citrate reduction method, and after the preparation is completed, 100ml of the colloidal gold solution is placed in a beaker and mixed with 0.2MK 2 CO 3 Adjust to pH 8.0, add 2.0mg mouse anti-human IgM monoclonal antibody to 100ml colloidal gold solution, then slowly add 0.2M K 2 CO 3 to adjust the colloidal gold solution to pH 9.5, add K 2 CO 3 for 5 minutes , then stirred at room temperature for 30 minutes, added bovine serum albumin with a final concentration of 10mg/ml, blocked with 1mg/ml polyvinylpyrrolidone for 20 minutes, centrifuged at 12000r/m for 30 minutes, discarded the supernatant, reconstituted with buffer to 50ml, and pressed 1ml Spread the solution evenly on the glass fiber membrane at a ratio of 20 cm 2 , and then place it in a drying room at a temperature of 20°C and a humidity of less than 30%, and dry for 5 hours.
所述缓冲液由以下方法制得:称取0.06g的NaH2PO4·2H2O和0.58g的Na2HPO4·12H2O,加纯化水80.0mL,搅拌使充分溶解后加入0.80g的NaCl和0.5g烷基糖苷,充分混匀,定容至100ml,测定pH值为7.5。The buffer solution is prepared by the following method: Weigh 0.06g of NaH 2 PO 4 ·2H 2 O and 0.58g of Na 2 HPO 4 ·12H 2 O, add 80.0mL of purified water, stir to fully dissolve, then add 0.80g NaCl and 0.5 g of alkyl glucoside, mix well, make the volume to 100 ml, and measure the pH value to be 7.5.
所述烷基糖苷的碳链长度为C8~C10;所述反应膜为硝酸纤维素膜;所述样品垫为玻璃纤维膜。The carbon chain length of the alkyl glycoside is C8-C10; the reaction membrane is a nitrocellulose membrane; and the sample pad is a glass fiber membrane.
实施例2、本发明单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒Embodiment 2, the immunochromatographic detection kit of herpes simplex virus type II IgM antibody of the present invention
本实施例的试剂盒由试剂条和塑料卡组装而成,所述试剂条的宽度为4mm,包括底板,所述底板上粘贴有带有检测线(T)和质控线(C)的反应膜,所述反应膜靠近检测线(T)的一端依次叠加粘贴有胶体金垫、样品垫,T线一端搭接胶体金垫的1/5处粘贴,样品垫搭接胶体金垫的1/3处粘贴;所述反应膜靠近质控线(C)的一端叠加粘贴有吸收垫,搭接吸样垫的1/10处粘贴,所述反应膜上检测线(T)包被了单纯疱疹病毒II型抗原,所述反应膜上质控线(C)包被了羊抗鼠IgG抗体,所述胶体金垫上包被了胶体金标记的鼠抗人IgM单克隆抗体。The test kit of the present embodiment is assembled by a reagent strip and a plastic card. The width of the reagent strip is 4 mm, and includes a base plate on which a test line (T) and a quality control line (C) are pasted on the base plate. A colloidal gold pad and a sample pad are superimposed and pasted on one end of the reaction film close to the detection line (T) in sequence, one end of the T line overlaps 1/5 of the colloidal gold pad, and the sample pad overlaps 1/5 of the colloidal gold pad. Paste at 3 places; the end of the reaction film close to the quality control line (C) is superimposed and pasted with an absorbent pad, and the 1/10 place of the overlapping suction pad is pasted, and the detection line (T) on the reaction film is coated with herpes simplex Virus type II antigen, the quality control line (C) on the reaction membrane is coated with goat anti-mouse IgG antibody, and the mouse anti-human IgM monoclonal antibody labeled with colloidal gold is coated on the colloidal gold pad.
所述反应膜由以下方法制得:用缓冲液将单纯疱疹病毒II型抗原稀释至包被浓度为1.2mg/ml,将羊抗鼠IgG抗体稀释至包被浓度为1.8mg/ml,在反应膜上分别划线单纯疱疹病毒II型抗原检测线和羊抗鼠IgG抗体质控线,划线后将反应膜置于干燥间,温度25℃,湿度小于30%,干燥4小时;The reaction membrane is prepared by the following method: the herpes simplex virus type II antigen is diluted to a coating concentration of 1.2 mg/ml with a buffer, and the goat anti-mouse IgG antibody is diluted to a coating concentration of 1.8 mg/ml. Scribe the detection line of herpes simplex virus type II antigen and the quality control line of goat anti-mouse IgG antibody on the membrane respectively. After scribing, place the reaction membrane in a drying room at a temperature of 25°C and a humidity of less than 30% for 4 hours;
所述胶体金垫由以下方法制得:以氯金酸-柠檬酸三钠还原法制备直径为20nm的胶体金溶液,制备完成后取100ml胶体金液放在烧杯内,用0.2M K2CO3调至pH8.0,按100ml胶体金溶液加入2.0mg鼠抗人IgM单克隆抗体,再缓慢添加0.2M K2CO3将胶体金溶液调至pH9.5,添加K2CO3的时间为5分钟,然后室温搅拌30分钟,加入终浓度为10mg/ml牛血清白蛋白,1mg/ml聚乙烯吡咯烷酮封闭30分钟,12000r/m离心30分钟,弃上清,用缓冲液复溶至50ml,按1ml溶液铺20cm2的比例均匀地铺在玻璃纤维膜上,再置于干燥间,温度25℃,湿度小于30%,干燥5小时。The colloidal gold pad is prepared by the following method: a colloidal gold solution with a diameter of 20nm is prepared by the chloroauric acid-trisodium citrate reduction method, and after the preparation is completed, 100ml of the colloidal gold solution is placed in a beaker and mixed with 0.2MK 2 CO 3 Adjust to pH 8.0, add 2.0mg mouse anti-human IgM monoclonal antibody to 100ml colloidal gold solution, then slowly add 0.2M K 2 CO 3 to adjust the colloidal gold solution to pH 9.5, add K 2 CO 3 for 5 minutes , then stirred at room temperature for 30 minutes, added bovine serum albumin with a final concentration of 10mg/ml, blocked with 1mg/ml polyvinylpyrrolidone for 30 minutes, centrifuged at 12000r/m for 30 minutes, discarded the supernatant, reconstituted with buffer to 50ml, and pressed 1ml Spread the solution evenly on the glass fiber membrane at a ratio of 20 cm 2 , and then place it in a drying room at a temperature of 25°C and a humidity of less than 30%, and dry for 5 hours.
所述缓冲液由以下方法制得:称取0.06g的NaH2PO4·2H2O和0.58g的Na2HPO4·12H2O,加纯化水80.0mL,搅拌使充分溶解后加入0.90g的NaCl和2.0g烷基糖苷,充分混匀,定容至100ml,测定pH值为8.0。The buffer solution is prepared by the following method: Weigh 0.06g of NaH 2 PO 4 ·2H 2 O and 0.58g of Na 2 HPO 4 ·12H 2 O, add 80.0mL of purified water, stir to fully dissolve, then add 0.90g NaCl and 2.0 g of alkyl glucosides, mix well, make the volume to 100 ml, and measure the pH value to be 8.0.
所述烷基糖苷的碳链长度为C8~C10;所述反应膜为硝酸纤维素膜;所述样品垫为玻璃纤维膜。The carbon chain length of the alkyl glycoside is C8-C10; the reaction membrane is a nitrocellulose membrane; and the sample pad is a glass fiber membrane.
实施例3、本发明单纯疱疹病毒II型IgM抗体的免疫层析检测试剂盒Embodiment 3, the immunochromatographic detection kit of herpes simplex virus type II IgM antibody of the present invention
本实施例的试剂盒由试剂条和塑料卡组装而成,所述试剂条的宽度为4mm,包括底板,所述底板上粘贴有带有检测线(T)和质控线(C)的反应膜,所述反应膜靠近检测线(T)的一端依次叠加粘贴有胶体金垫、样品垫,T线一端搭接胶体金垫的1/5处粘贴,样品垫搭接胶体金垫的1/3处粘贴;所述反应膜靠近质控线(C)的一端叠加粘贴有吸收垫,搭接吸样垫的1/10处粘贴,所述反应膜上检测线(T)包被了单纯疱疹病毒II型抗原,所述反应膜上质控线(C)包被了羊抗鼠IgG抗体,所述胶体金垫上包被了胶体金标记的鼠抗人IgM单克隆抗体。The test kit of the present embodiment is assembled by a reagent strip and a plastic card. The width of the reagent strip is 4 mm, and includes a base plate on which a test line (T) and a quality control line (C) are pasted on the base plate. A colloidal gold pad and a sample pad are superimposed and pasted on one end of the reaction film close to the detection line (T) in sequence, one end of the T line overlaps 1/5 of the colloidal gold pad, and the sample pad overlaps 1/5 of the colloidal gold pad. Paste at 3 places; the end of the reaction film close to the quality control line (C) is superimposed and pasted with an absorbent pad, and the 1/10 place of the overlapping suction pad is pasted, and the detection line (T) on the reaction film is coated with herpes simplex Virus type II antigen, the quality control line (C) on the reaction membrane is coated with goat anti-mouse IgG antibody, and the mouse anti-human IgM monoclonal antibody labeled with colloidal gold is coated on the colloidal gold pad.
所述反应膜由以下方法制得:用缓冲液将单纯疱疹病毒II型抗原稀释至包被浓度为1.0mg/ml,将羊抗鼠IgG抗体稀释至包被浓度为1.6mg/ml,在反应膜上分别划线单纯疱疹病毒II型抗原检测线和羊抗鼠IgG抗体质控线,划线后将反应膜置于干燥间,温度20℃,湿度小于30%,干燥5小时;The reaction membrane is prepared by the following method: the herpes simplex virus type II antigen is diluted to a coating concentration of 1.0 mg/ml with a buffer, and the goat anti-mouse IgG antibody is diluted to a coating concentration of 1.6 mg/ml. Scribe the detection line of herpes simplex virus type II antigen and the quality control line of goat anti-mouse IgG antibody on the membrane respectively. After scribing, place the reaction membrane in a drying room at a temperature of 20°C and a humidity of less than 30% for 5 hours;
所述胶体金垫由以下方法制得:以氯金酸-柠檬酸三钠还原法制备直径为20nm的胶体金溶液,制备完成后取100ml胶体金液放在烧杯内,用0.2M K2CO3调至pH8.0,按100ml胶体金溶液加入2.0mg鼠抗人IgM单克隆抗体,再缓慢添加0.2M K2CO3将胶体金溶液调至pH9.5,添加K2CO3的时间为5分钟,然后室温搅拌30分钟,加入终浓度为10mg/ml牛血清白蛋白,1mg/ml聚乙烯吡咯烷酮封闭25分钟,12000r/m离心30分钟,弃上清,用缓冲液复溶至50ml,按1ml溶液铺20cm2的比例均匀地铺在玻璃纤维膜上,再置于干燥间,温度20℃,湿度小于30%,干燥5小时。The colloidal gold pad is prepared by the following method: a colloidal gold solution with a diameter of 20nm is prepared by the chloroauric acid-trisodium citrate reduction method, and after the preparation is completed, 100ml of the colloidal gold solution is placed in a beaker and mixed with 0.2MK 2 CO 3 Adjust to pH 8.0, add 2.0mg mouse anti-human IgM monoclonal antibody to 100ml colloidal gold solution, then slowly add 0.2M K 2 CO 3 to adjust the colloidal gold solution to pH 9.5, add K 2 CO 3 for 5 minutes , then stirred at room temperature for 30 minutes, added bovine serum albumin with a final concentration of 10mg/ml, blocked with 1mg/ml polyvinylpyrrolidone for 25 minutes, centrifuged at 12000r/m for 30 minutes, discarded the supernatant, reconstituted to 50ml with buffer, and pressed 1ml Spread the solution evenly on the glass fiber membrane at a ratio of 20 cm 2 , and then place it in a drying room at a temperature of 20°C and a humidity of less than 30%, and dry for 5 hours.
所述缓冲液由以下方法制得:称取0.06g的NaH2PO4·2H2O和0.58g的Na2HPO4·12H2O,加纯化水80.0mL,搅拌使充分溶解后加入0.8g的NaCl和1.0g烷基糖苷,充分混匀,定容至100ml,测定pH值为7.8。The buffer solution is prepared by the following method: Weigh 0.06g of NaH 2 PO 4 ·2H 2 O and 0.58g of Na 2 HPO 4 ·12H 2 O, add 80.0mL of purified water, stir to fully dissolve, then add 0.8g NaCl and 1.0 g of alkyl glucoside, mix well, make the volume to 100 ml, and measure the pH value to be 7.8.
所述烷基糖苷的碳链长度为C8~C10;所述反应膜为硝酸纤维素膜;所述样品垫为玻璃纤维膜。The carbon chain length of the alkyl glycoside is C8-C10; the reaction membrane is a nitrocellulose membrane; and the sample pad is a glass fiber membrane.
对比例1Comparative example 1
与实施例3相比,本对比例的区别仅在于:缓冲液中不添加烷基糖苷。Compared with Example 3, the only difference in this comparative example is that no alkyl glycoside is added to the buffer.
对比例2Comparative example 2
与实施例3相比,本对比例的区别仅在于:缓冲液中添加4.0g烷基糖苷。Compared with Example 3, the only difference in this comparative example is that 4.0 g of alkyl glycosides are added to the buffer.
试验例一Test example one
使用实施例1~3和对比例1~2的试剂盒,以及市售试剂盒(单纯疱疹病毒II型(IgM)抗体检测试剂盒,购自福建省明溪海天蓝波生物技术有限公司),在不同环境条件下,同时对12份单纯疱疹病毒II型IgM抗体阳性血清样本进行检测,结果如下:Using the kits of Examples 1-3 and Comparative Examples 1-2, and a commercially available kit (herpes simplex virus type II (IgM) antibody detection kit, purchased from Fujian Mingxi Haitian Lanbo Biotechnology Co., Ltd.), Under different environmental conditions, 12 positive serum samples of herpes simplex virus type II IgM antibody were detected at the same time, and the results were as follows:
1)实施例1~3和对比例1~2的试剂盒,以及市售试剂盒在常温条件(温度:25±2℃,湿度:58±2%)下对12例血清样本的检测结果均为有效,且12例血清样本的T线均呈深紫红色,与C线颜色基本一致,均显示出阳性;其中,实施例1~3试剂盒在4~6分钟内可判定结果,对比例1~2试剂盒和市售试剂盒在10~20分钟内可判定结果。1) The test results of the 12 cases of serum samples under normal temperature conditions (temperature: 25 ± 2°C, humidity: 58 ± 2%) of the kits of Examples 1-3 and Comparative Examples 1-2, and commercially available kits were all the same. It is effective, and the T-lines of 12 cases of serum samples are all dark purple, which is basically the same color as the C-line, and all show positive; Among them, the test kits of Examples 1-3 can determine the results within 4-6 minutes, and the comparative example 1-2 kits and commercially available kits can determine the results within 10-20 minutes.
2)见下表1:实施例1~3试剂盒在低温条件(温度:8±2℃,湿度:58±2%)下对12例血清样本的检测结果均为有效,且均显示出阳性,可在20分钟内判定结果,并且12例血清样本的T线均呈深紫红色,与C线颜色基本一致。而对比例1试剂盒和市售试剂盒在低温环境下均出现了漏检情况,有3例阳性样本检出为阴性,并且层析速度慢,显色时间延长长,并且检测线显色浅,灵敏度和准确度降低;而对比例2试剂盒在低温环境下出现了2例无效,同时显色时间也延长,检测线显色浅,灵敏度和准确度降低。2) See Table 1 below: The test results of the kits in Examples 1-3 are all effective and positive for 12 serum samples under low temperature conditions (temperature: 8±2°C, humidity: 58±2%) , the results can be judged within 20 minutes, and the T-lines of 12 serum samples were all dark purple, which was basically the same color as the C-line. However, both the kit of Comparative Example 1 and the commercially available kit had missed detection under low temperature environment, and 3 cases of positive samples were detected as negative, and the chromatographic speed was slow, the color development time was prolonged, and the detection line was light in color. , the sensitivity and accuracy decreased; while the kit of Comparative Example 2 was invalid in 2 cases under low temperature environment, and the color development time was also prolonged, the detection line showed light color, and the sensitivity and accuracy decreased.
表1各试剂盒在低温条件(温度:8±2℃,湿度:58±2%)下的检测结果Table 1 Test results of each kit under low temperature conditions (temperature: 8±2°C, humidity: 58±2%)
(注:表格中的显色时间和显色深浅均针对检测线,“+”表示浅紫红色,“++”表示深紫红色)(Note: The color development time and color depth in the table are all for the detection line, "+" means light purple red, "++" means deep purple red)
3)见下表2:实施例1~3试剂盒在高湿条件(温度:25±2℃,湿度:90±2%)下对12例血清样本的检测结果均为有效,且均显示出阳性,可在10~15分钟内判定结果,并且12例血清样本的T线均呈深紫红色,与C线颜色基本一致。而对比例1试剂盒在高湿条件下出现了4例无效,并且有效样本中T线显色均较浅;对比例2试剂盒和市售试剂盒在高湿条件下同样出现了多例无效,并且检测出2例假阴性,与实施例相比,检测灵敏度和准确度均明显降低。3) See Table 2 below: The test results of the kits in Examples 1 to 3 are all effective for 12 serum samples under high humidity conditions (temperature: 25±2°C, humidity: 90±2%), and all show If it is positive, the result can be judged within 10-15 minutes, and the T-lines of the 12 serum samples are all dark purple, which is basically the same color as the C-line. However, the kit of Comparative Example 1 was invalid in 4 cases under high humidity conditions, and the T-line color development in the valid samples was lighter; the kit of Comparative Example 2 and the commercially available kit also had many cases of invalidation under high humidity conditions. , and detected 2 cases of false negatives, compared with the embodiment, the detection sensitivity and accuracy were significantly reduced.
另外,在高湿条件下,本发明实施例1~3试剂盒的T线和C线在呈色后60分钟内仍保持清晰不褪色,也没有变宽;而对比例1试剂盒和市售试剂盒的T线和C线在显色后即开始出现褪色、变宽、扩散的现象,对比例2试剂盒的T线和C线在显色后约5分钟后开始出现褪色、变宽、扩散的现象,说明本发明试剂盒能在高湿条件下,在一定时间内能维持T线和C线的稳定,加长结果判定时间。In addition, under high-humidity conditions, the T-line and C-line of the kits of Examples 1-3 of the present invention remained clear and did not fade or widen within 60 minutes after coloring; while the kits of Comparative Example 1 and the commercially available The T-line and C-line of the kit began to fade, widen, and diffuse after color development, and the T-line and C-line of the kit in Comparative Example 2 began to fade, widen, and diffuse about 5 minutes after color development. The phenomenon of diffusion shows that the kit of the present invention can maintain the stability of T-line and C-line within a certain period of time under high-humidity conditions, prolonging the result judgment time.
表2各试剂盒在高湿条件(温度:25±2℃,湿度:90±2%)下的检测结果Table 2 Test results of each kit under high humidity conditions (temperature: 25±2°C, humidity: 90±2%)
(注:各试剂盒在高湿环境下放置30min后再进行试验,表格中的显色时间和显色深浅均针对检测线,“+”表示浅紫红色,“++”表示深紫红色)(Note: each kit is tested after being placed in a high-humidity environment for 30 minutes. The color development time and color depth in the table are based on the detection line, "+" means light purple red, "++" means deep purple red)
本发明内容仅仅举例说明了要求保护的一些具体实施方案,其中一个或更多个技术方案中所记载的技术特征可以与任意的一个或多个技术方案相组合,这些经组合而得到的技术方案也在本申请保护范围内,就像这些经组合而得到的技术方案已经在本发明公开内容中具体记载一样。The summary of the present invention only exemplifies some specific embodiments of the claims, wherein the technical features recorded in one or more technical solutions can be combined with any one or more technical solutions, and the technical solutions obtained by these combinations It is also within the scope of protection of the present application, just as these combined technical solutions have been specifically recorded in the disclosure content of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710008363.3A CN106771193B (en) | 2017-01-05 | 2017-01-05 | A kind of immunochromatographytest test kit of herpes simplex virus type II IgM antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710008363.3A CN106771193B (en) | 2017-01-05 | 2017-01-05 | A kind of immunochromatographytest test kit of herpes simplex virus type II IgM antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106771193A CN106771193A (en) | 2017-05-31 |
CN106771193B true CN106771193B (en) | 2018-04-06 |
Family
ID=58950611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710008363.3A Expired - Fee Related CN106771193B (en) | 2017-01-05 | 2017-01-05 | A kind of immunochromatographytest test kit of herpes simplex virus type II IgM antibody |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106771193B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109991416A (en) * | 2019-03-12 | 2019-07-09 | 江苏伯纳德生物科技发展有限公司 | A kind of immunochromatographyassay assay reagent box and preparation method thereof |
CN113759111A (en) * | 2021-08-24 | 2021-12-07 | 深圳芬德生物技术有限公司 | Test card for detecting antibodies to Corynebacterium pseudotuberculosis and its application and kit |
CN113788892B (en) * | 2021-11-16 | 2022-02-18 | 南京黎明生物制品有限公司 | Rapid detection kit applying anti-herpes simplex virus monoclonal antibody |
CN116559443A (en) * | 2023-05-12 | 2023-08-08 | 上海浩兆实业有限公司 | Application of herpesvirus of carp type II ORF66 protein in colloidal gold immunochromatography |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1431507A (en) * | 2003-01-24 | 2003-07-23 | 湖州瑞泽生物技术有限公司 | Immune colloidal gold reagent for detecting IgM antibody of herpes simplex virus II type and its preparing method |
JP2008014751A (en) * | 2006-07-05 | 2008-01-24 | Denka Seiken Co Ltd | Membrane assay and kit using colored latex particles |
JP2009186359A (en) * | 2008-02-07 | 2009-08-20 | Tanaka Kikinzoku Kogyo Kk | Sample treatment reagent composition for immunological measurement |
CN102426231B (en) * | 2011-09-15 | 2014-09-03 | 长沙三诺生物传感技术股份有限公司 | Immunochromatography reagent strip and sealing agent composition used for same |
CN104880414B (en) * | 2015-05-27 | 2016-08-17 | 广州华弘生物科技有限公司 | TSH immune chromatography reagent kit and preparation method thereof |
CN105542014B (en) * | 2015-12-24 | 2020-01-17 | 菲鹏生物股份有限公司 | TP recombinant antigen and preparation method and application thereof |
-
2017
- 2017-01-05 CN CN201710008363.3A patent/CN106771193B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN106771193A (en) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2853894B1 (en) | Diagnostic kits and immunoassay methods for diagnosis and differentiation of African Swine Fever Virus (ASFV) and Classical Swine Fever Virus (CSFV) | |
CN111537748B (en) | Test strip and kit for detecting novel human coronavirus IgM antibody and preparation method thereof | |
CN106771193B (en) | A kind of immunochromatographytest test kit of herpes simplex virus type II IgM antibody | |
EP3128324B1 (en) | Immunochromatographic assay method | |
CN113533721B (en) | Colloidal gold method detection test strip for influenza A/B virus antigen and preparation method thereof | |
CN111983217B (en) | Sample treatment fluid and application thereof | |
CN107144693A (en) | Detect CD4 in blood+Lateral chromatography kit of T cell quantity and preparation method thereof | |
WO2021159703A1 (en) | Immunochromatographic kit for rapidly detecting novel coronavirus n protein, and preparation method and application thereof | |
CN111751527A (en) | Novel coronavirus IgG and IgM antibody detection kit and preparation method and application thereof | |
EP2290367A1 (en) | Method for detecting objective substance and kit for detecting objective substance | |
CN112305218A (en) | A kind of novel coronavirus antibody colloidal gold immune lateral chromatography detection method and its application | |
WO2022053072A1 (en) | Reagent card for quantitatively detecting helicobacter pylori antibodies by fluorescence chromatography and detection method | |
CN110940806A (en) | Adenovirus and rotavirus quantum dot joint detection test strip and preparation method and application thereof | |
CN115267185A (en) | Helicobacter pylori antigen colloidal gold detection reagent strip | |
CN101858916A (en) | Syphilis-specific IgM antibody colloidal gold immunochromatography detection reagent strip and preparation method thereof | |
CN102539768B (en) | EB (Epstein-Barr) virus Zta IgA (Immunoglobulin A) antibody colloidal gold detection kit and preparation method thereof | |
JP4115728B2 (en) | Composition for flow-through type inspection method, kit and inspection method using the same | |
CN113321715A (en) | Novel coronavirus antigen and detection use thereof | |
CN114720450A (en) | A new coronavirus Raman-labeled antigen detection test strip and preparation method thereof | |
CN219201611U (en) | Multi-target test strip and multi-target detection card | |
CN113466452A (en) | Novel coronavirus IgM/IgG antibody detection kit | |
CN111208292B (en) | Mycoplasma pneumoniae antibody IgM immunoassay kit, preparation method and use method thereof | |
CN115248308A (en) | Application of poly-L-dopa nanoparticles in the preparation of immunochromatographic test strips | |
CN113687070A (en) | High-sensitivity semi-quantitative kit for detecting novel coronavirus neutralizing antibody | |
CN102435744A (en) | Toxoplasma gondii total antibody colloidal gold immunochromatographic assay reagent strip and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210409 Address after: 430021 No.3, 20 / F, building 4, building 3, 4, 6, oceanwide international SOHO City, Central Business District, Jianghan District, Wuhan City, Hubei Province Patentee after: Wuhan Rongyi Biotechnology Co.,Ltd. Address before: 510530 Guangzhou High-tech Industrial Development Zone, Guangdong Province Patentee before: GUANGZHOU HUAHONG BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180406 |
|
CF01 | Termination of patent right due to non-payment of annual fee |